Markets
MA Stock Indexes
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Local Stocks
ALEXZA PHARMA (NQ: ALXA)
4.590 USD  +0.080 (+1.77%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about ALEXZA PHARMA
 
Alexza Reports 2013 First Quarter Financial Results
May 14, 2013
Management to Review Results and Provide Business Update in Conference Call Scheduled Today for 5:00 p.m. Eastern Time Read More
from PR Newswire
Free Research Reports on ALXA, DIS, SKYW, THI Issued by the Paragon Report
May 09, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
Squawk Box Stocks Reports on: J. C. Penney Company, Inc. (NYSE: JCP), ValueClick, Inc. (NASDAQ: VCLK), Alexza Pharmaceuticals Inc. (NASDAQ: ALXA), Affymax, Inc. (NASDAQ: AFFY)
May 09, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
Alexza Announces Conference Call to Discuss Agreement with Teva to Market ADASUVE® in the U.S.
May 08, 2013
Call Scheduled Today for 9:00 a.m. Eastern Time Read More
from PR Newswire
Teva and Alexza Announce Teva's License to Market ADASUVE® in the U.S.
May 08, 2013
Adasuve® (loxapine) inhalation powder is approved in the U.S. for the acute treatment of agitation associated with schizophrenia and bipolar disorder Read More
from PR Newswire
Teva and Alexza Announce Teva’s License to Market ADASUVE® in the U.S.
May 08, 2013
from Business Wire News Releases
Alexza Pharmaceuticals to Present at Antiepileptic Drug and Device Trials (AED) XII Conference Highlighting Advances in the Treatment of Epilepsy
May 06, 2013
from PR Newswire
Update: Alexza to Report 2013 First Quarter Financial Results on Tuesday, May 14, 2013
May 01, 2013
from PR Newswire
Alexza to Report 2013 First Quarter Financial Results on Thursday, May 9, 2013
April 22, 2013
from PR Newswire
Alexza Reports 2012 Fourth Quarter and Full Year Financial Results
March 26, 2013
Management to Review Results and Provide Business Updates in Conference Call Scheduled Today for 5:00 p.m. Eastern Time Read More
from PR Newswire
Peter W. Schineller Joins Alexza Pharmaceuticals as Senior Vice President and Chief Commercial Officer
March 13, 2013
from PR Newswire
Alexza to Report 2012 Year-End Financial Results on Tuesday, March 26, 2013
March 06, 2013
from PR Newswire
Alexza Pharmaceuticals' Corporate Presentation to Be Webcast at Three Upcoming Investor Conferences
February 25, 2013
from PR Newswire
Alexza Receives Marketing Authorization for ADASUVE® (Staccato® Loxapine) in the European Union
February 21, 2013
from PR Newswire
Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry's Success
February 14, 2013
RDInvesting Provides Stocks Research on Alexza Pharmaceuticals and Savient Pharmaceuticals Read More
from Marketwired News Releases
Mergers and Acquisitions on the Rise in 2013 as Big Pharma Companies Hold Record Amounts of Cash on Hand
January 22, 2013
Five Star Equities Provides Stock Research on Alexza Pharmaceuticals and Avanir Pharmaceuticals Read More
from Marketwired News Releases
The Real Story Behind AMRN, MDBX, ALXA and DNDN
January 07, 2013
from Marketwired News Releases
Alexza Pharmaceuticals Appoints J. Kevin Buchi to its Board of Directors
January 03, 2013
from PR Newswire
Should Recent Insider Selling on FFIV, RHT, ALXA and VPHM Matter to You?
December 28, 2012
from Marketwired News Releases
Strategy Behind Our Success, We Get in Early: ALXA, RAD, AMRN and HLF
December 28, 2012
from Marketwired News Releases
Special Offer for Shareholders of ALXA, RAD, AMRN and HLF
December 27, 2012
from Marketwired News Releases
Secrets to Making Money in ALXA, RAD, AMRN and HLF
December 26, 2012
from Marketwired News Releases
U.S. FDA Approves Alexza's ADASUVE® (loxapine) Inhalation Powder for the Acute Treatment of Agitation Associated with Schizophrenia or Bipolar I Disorder in Adults
December 21, 2012
from PR Newswire
Perfect Trade Setups, How to Play ALXA, ARC, FOE and SCS
December 21, 2012
from Marketwired News Releases
The Reason It Trades, What's Moving DNDN, VNDA, LFVN and ALXA
December 20, 2012
from Marketwired News Releases
Before the Crowd, How We Found MU, MCP, ALXA and BBY
December 19, 2012
from Marketwired News Releases
Key to Success, How to Profit: MU, MCP, ALXA and BBY
December 18, 2012
from Marketwired News Releases
The CHMP Renders a Positive Opinion Recommending Approval of Marketing Authorization for Alexza Pharmaceuticals (ALXA) Product in the EU
December 17, 2012
category Stocks
from TransWorldNews Current Releases
The Real Story Behind ALIM, ZAZA, NEON and ALXA
December 17, 2012
from Marketwired News Releases
The CHMP Delivers a Positive Opinion Recommending Grant of Marketing Authorization for ADASUVE® (Staccato® Loxapine) in the European Union
December 14, 2012
from PR Newswire
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here